IN2013MU02100AIN2100MU2013AIN2013MU02100AIN 2013MU02100 AIN2013MU02100 AIN 2013MU02100AIN 2100MU2013 AIN2100MU2013 AIN 2100MU2013AIN 2013MU02100 AIN2013MU02100 AIN 2013MU02100A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt LtdfiledCriticalWockhardt Ltd
Priority to US14/767,625priorityCriticalpatent/US20160074333A1/en
Priority to KR1020157032734Aprioritypatent/KR20160021095A/ko
Priority to RU2015143891Aprioritypatent/RU2015143891A/ru
Priority to PCT/IB2014/062232prioritypatent/WO2014203137A2/en
Priority to CN201480017958.XAprioritypatent/CN105073100A/zh
Priority to IN2100MU2013prioritypatent/IN2013MU02100A/en
Priority to BR112015024348Aprioritypatent/BR112015024348A2/pt
Publication of IN2013MU02100ApublicationCriticalpatent/IN2013MU02100A/en
Preparations for use in the treatment or prevention of graft-versus-graft disease or diffuse nodal bleeding or venous occlusive disease associated with hematopoietic allograft transplantation